240 related articles for article (PubMed ID: 33098033)
21. Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis.
Salm LP; Van der Hiel B; Stokkel MP
Nucl Med Commun; 2012 Sep; 33(9):907-16. PubMed ID: 22714006
[TBL] [Abstract][Full Text] [Related]
22. An Extremely Rare Intersection: Neurolymphomatosis in a Patient with Burkitt Lymphoma Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Oner AO; Okuyucu K; Alagoz E; Battal B; Arslan N
World J Nucl Med; 2016 Sep; 15(3):209-11. PubMed ID: 27651745
[TBL] [Abstract][Full Text] [Related]
23. The Diagnostic Dilemma of Neurolymphomatosis.
Shree R; Goyal MK; Modi M; Gaspar BL; Radotra BD; Ahuja CK; Mittal BR; Prakash G
J Clin Neurol; 2016 Jul; 12(3):274-81. PubMed ID: 27449910
[TBL] [Abstract][Full Text] [Related]
24. [Neurolymphomatosis Mimicking Inflammatory Neuropathy with Slight FDG Uptake on PET/CT and Distinct MRI Abnormalities in the Brachial Plexus: A Case Report].
Shima T; Tsujino A
Brain Nerve; 2020 Sep; 72(9):987-992. PubMed ID: 32934188
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features of neuropathy associated with lymphoma.
Tomita M; Koike H; Kawagashira Y; Iijima M; Adachi H; Taguchi J; Abe T; Sako K; Tsuji Y; Nakagawa M; Kanda F; Takeda F; Sugawara M; Toyoshima I; Asano N; Sobue G
Brain; 2013 Aug; 136(Pt 8):2563-78. PubMed ID: 23884813
[TBL] [Abstract][Full Text] [Related]
26. Neurolymphomatosis, a rare manifestation of peripheral nerve involvement in lymphomas: Suggestive features and diagnostic challenges.
Campagnolo M; Cacciavillani M; Cavallaro T; Ferrari S; Gasparotti R; Zambello R; Briani C
J Peripher Nerv Syst; 2020 Sep; 25(3):312-315. PubMed ID: 32627254
[TBL] [Abstract][Full Text] [Related]
27. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis.
Kanter P; Zeidman A; Streifler J; Marmelstein V; Even-Sapir E; Metser U; Stein GY; Cohen AM
Eur J Haematol; 2005 Jan; 74(1):66-9. PubMed ID: 15613109
[TBL] [Abstract][Full Text] [Related]
28. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
Lin M; Kilanowska J; Taper J; Chu J
Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824
[TBL] [Abstract][Full Text] [Related]
29. Recurrence of nasal type NK/T cell lymphoma presenting as neurolymphomatosis on 18F-FDG PET/CT: A case report and literature review.
Pan Q; Luo Y
Medicine (Baltimore); 2020 Jan; 99(1):e18640. PubMed ID: 31895825
[TBL] [Abstract][Full Text] [Related]
30. Fluorothymidine PET/CT in neurolymphomatosis.
Biswal CK; Mittal BR; Shukla J; Vatsa R; Bhattacharya A; Prabhakar S
Clin Nucl Med; 2015 May; 40(5):e290-2. PubMed ID: 25546221
[TBL] [Abstract][Full Text] [Related]
31. High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma.
Matsue K; Hayama BY; Iwama K; Koyama T; Fujiwara H; Yamakura M; Takeuchi M; O'uchi T
Cancer; 2011 Oct; 117(19):4512-21. PubMed ID: 21448935
[TBL] [Abstract][Full Text] [Related]
32. A Case Series of Neurolymphomatosis: Role of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan Reiterated.
Gupta M; Pasricha S; Ahmed R; Choudhury PS
Indian J Nucl Med; 2023; 38(1):44-49. PubMed ID: 37180178
[TBL] [Abstract][Full Text] [Related]
33. Neurolymphomatosis of the lumbosacral plexus and its branches: case series and literature review.
Bourque PR; Sampaio ML; Warman-Chardon J; Samaan S; Torres C
BMC Cancer; 2019 Nov; 19(1):1149. PubMed ID: 31775683
[TBL] [Abstract][Full Text] [Related]
34. Neurolymphomatosis as a late relapse of non-Hodgkin's lymphoma detected by 18F-FDG PET/CT: a case report.
Kajáry K; Molnár Z; Mikó I; Barsi P; Lengyel Z; Szakáll S
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):39-42. PubMed ID: 23683830
[TBL] [Abstract][Full Text] [Related]
35. Neurolymphomatosis of the Sciatic and Tibial Nerves.
Yaseen MT; Aziz PAA; Siddique K; Tariq TA
J Coll Physicians Surg Pak; 2019 Dec; 29(12):S86-S88. PubMed ID: 31779751
[TBL] [Abstract][Full Text] [Related]
36. Neurolymphomatosis of multifocal peripheral nerve involvement: a case report.
Peng L; Yang H; Zhao Y; He J; Stebbing J; Chen B
Ann Palliat Med; 2022 Jul; 11(7):2529-2537. PubMed ID: 34670378
[TBL] [Abstract][Full Text] [Related]
37. Diffuse large B-cell lymphoma relapse presenting as extensive neurolymphomatosis.
Nepal P; Batchala PP; Rehm PK; Fadul CE
Neuroradiol J; 2020 Jun; 33(3):230-235. PubMed ID: 32401669
[TBL] [Abstract][Full Text] [Related]
38. 18F-FDG PET/CT/MRI Fusion Images Showing Cranial and Peripheral Nerve Involvement in Neurolymphomatosis.
Trevisan AC; Ribeiro FB; Itikawa EN; Alexandre LS; Pitella FA; Santos AC; Simões BP; Wichert-Ana L
Indian J Nucl Med; 2017; 32(1):77-78. PubMed ID: 28242998
[TBL] [Abstract][Full Text] [Related]
39. Neurolymphomatosis as an Initial Presentation of Non Hodgkins Lymphoma: A Case Report.
Rohatgi S; Nirhale S; Rao P; Naphade P; Khan F
Neurol India; 2023; 71(5):991-993. PubMed ID: 37929441
[TBL] [Abstract][Full Text] [Related]
40. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era.
Khurana A; Novo M; Nowakowski GS; Ristow KM; Spinner RJ; Hunt CH; King RL; Lachance DH; Habermann TM; Micallef IN; Johnston PB
Blood Adv; 2021 Mar; 5(5):1379-1387. PubMed ID: 33661298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
